S. 3593 117th Congress
Telehealth Extension and Evaluation Act
Latest action, Feb 8, 2022: Read twice and referred to the Committee on Finance.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
4 cosponsors
Sponsored by Catherine Cortez Masto (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
2 D · 1 R · 1 I
- Democrat
- Republican
- Independent
Referred to: Senate: Finance Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
ALKERMES, INC.
PENN AVENUE PARTNERS
4 reports
4 reports
HCA
THE SMITH-FREE GROUP, LLC
4 reports
4 reports
TAPESTRYHEALTH
BROWNSTEIN HYATT FARBER SCHRECK, LLP
4 reports
4 reports
3 reports
3 reports
ATA ACTION
FAEGRE DRINKER BIDDLE & REATH LLP
3 reports
3 reports
GENEOSCOPY
VENABLE LLP
3 reports
3 reports
3 reports
All 25 of 35 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| ALKERMES, INC. | PENN AVENUE PARTNERS | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| AMERICAN CLINICAL LABORATORY ASSN | 4 | $3.9M | Q1 2022 | Q3 2022 | yes | |
| HCA | THE SMITH-FREE GROUP, LLC | 4 | $400K | Q1 2022 | Q3 2022 | yes |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | 4 | $1.0M | Q1 2022 | Q3 2022 | yes | |
| MYRIAD GENETICS, INC. | 4 | $970K | Q1 2022 | Q3 2022 | yes | |
| TAPESTRYHEALTH | BROWNSTEIN HYATT FARBER SCHRECK, LLP | 4 | $60K | Q1 2022 | Q3 2022 | yes |
| THE AMERICAN OCCUPATIONAL THERAPY ASSOCIATION, INC. (AOTA) | 4 | $630K | Q1 2022 | Q3 2022 | yes | |
| TRINITY HEALTH | 4 | $800K | Q1 2022 | Q3 2022 | yes | |
| AMERICAN MEDICAL ASSOCIATION | 3 | $15.4M | Q1 2022 | Q3 2022 | yes | |
| ATA ACTION | 3 | $360K | Q4 2022 | Q3 2022 | yes | |
| ATA ACTION | FAEGRE DRINKER BIDDLE & REATH LLP | 3 | $0 | Q4 2022 | Q3 2022 | yes |
| FRESENIUS MEDICAL CARE NORTH AMERICA | 3 | $5.6M | Q1 2022 | Q3 2022 | yes | |
| GENEOSCOPY | VENABLE LLP | 3 | $70K | Q1 2022 | Q3 2022 | yes |
| HCA HEALTHCARE, INC. | 3 | $2.7M | Q1 2022 | Q3 2022 | yes | |
| HOSPICE ACTION NETWORK | 3 | $850K | Q1 2022 | Q3 2022 | yes | |
| QUEST DIAGNOSTICS INCORPORATED | 3 | $830K | Q1 2022 | Q3 2022 | yes | |
| RECORA, INC. | THE CORMAC GROUP, LLC | 3 | $70K | Q4 2022 | Q3 2022 | yes |
| THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH | 3 | $150K | Q1 2022 | Q3 2022 | yes | |
| THE PARTNERSHIP TO ADVANCE VIRTUAL CARE (PAVC) | MCDERMOTT+ LLC | 3 | $90K | Q4 2022 | Q3 2022 | yes |
| AMERICAN COLLEGE OF PHYSICIAN SERVICES, INC. | 2 | $603K | Q4 2022 | Q3 2022 | yes | |
| AMERICAN COLLEGE OF PHYSICIANS | 2 | $138K | Q4 2022 | Q3 2022 | yes | |
| ASSOCIATION FOR MOLECULAR PATHOLOGY | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 2 | $40K | Q1 2022 | Q2 2022 | yes |
| CIGNA CORPORATION | INVARIANT LLC | 2 | $180K | Q1 2022 | Q2 2022 | yes |
| LABORATORY CORPORATION OF AMERICA HOLDINGS | KELLEY DRYE & WARREN LLP | 2 | $0 | Q4 2022 | Q3 2022 | yes |
| RESIDENTIAL EATING DISORDERS CONSORTIUM | CENTER ROAD SOLUTIONS | 2 | $60K | Q1 2022 | Q2 2022 | yes |